DKSH signs distribution agreement with India's TdB Labs
DKSH's Performance Materials business unit is a leading distributor of specialty chemicals and ingredients. Business development, marketing, sales, logistics and distribution services for TdB Labs' range of dextran derivatives and other polysaccharides will be provided to pharmaceutical companies and diagnostic laboratories in India.
TdB Labs' product portfolio includes dextran derivatives, fluorescent and non-fluorescent polysaccharide derivatives, as well as derivatives of other polysaccharides such as polysucrose, inulin, hyaluronic acid, trehalose and hydroxyethyl starch. Application areas include permeability, drug delivery, biomaterials and colitis research as well as applications in clinical product processing. TdB Labs' polysaccharide derivatives are also used in diagnostic kits and as molecular markers, while dextran sulfate is used as an anti-caking agent in cell culture media.
TdB Labs has entrusted DKSH to develop its pharmaceutical business in India. This is driven by DKSH's extensive distribution network, highly specialized commercial and technical teams, and strong logistics and value-added service capabilities, including technical and regulatory support.
Charlotte de Belder Tesséus, CEO of TdB Labs AB, commented:"DKSH's expertise and market presence in India provides us with a unique opportunity to meet the growing demand for polysaccharides in the region. Our team is excited about the possibilities this partnership brings and is committed to providing high-quality products and services to our new customers. I believe that together with DKSH, we will achieve extraordinary success and create lasting value for our stakeholders."
Vishal Jawale, Managing Director and Head of Country Management, DKSH India, commented:"We are delighted to partner with TdB Labs to bring its range of dextran derivatives and other polysaccharides for the pharmaceutical industry into India. TdB Labs' dextran and other polysaccharide derivatives are highly biocompatible and widely used in life sciences. We believe that our use of traditional and digital distribution and marketing channels will deliver superior results."
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
DKSH Opens Newly Enhanced Innovation Center in South Korea
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
DKSH Upgrades its Malaysia Innovation Center to Strengthen Technical Service Capabilities for the Southeast Asian Market
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
DKSH to Distribute Sunrise Metallic Pigments in Austria, Germany, and Switzerland
-
DKSH acquires CLMO Technology in Malaysia
-
DKSH receives ACD Responsible Distribution Certification for Personal Care Products in the US
-
DKSH partners with R-Biomeds to bring oncology and thyroid treatments to Cambodia
-
DKSH upgrades to new state-of-the-art Innovation Center in the Philippines
Recommend Reading
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Aldi Expands Its Ingredient Ban
-
“Oil Sheikhs” Buy Germany’s Chemical Crown: A €14.7 Billion Green Gamble or a Power Play in the Age of Carbon Neutrality?
-
IPEC Updates Excipient Qualification Guidance
-
From “10,000-Ton Bet” to “5,000-Ton Test”: Acore’s Polyetheramine Dilemma—Is This a Symptom of Industry Winter or the Prelude to Strategic Retreat?
-
Insufficient Downstream Demand, DMF Prices Remain Stable
-
Premium Global Chemical Sourcing Requests (1-5 Sep 2025)
-
Coke Market Prices Remain Stable for Now
-
Sodium Hydroxide Price Increase on February 25
-
Cost-Driven Restart, Supply-Demand Resonance Drives Acrylic Prices Higher